Page last updated: 2024-09-05

organophosphonates and Hand Dermatosis

organophosphonates has been researched along with Hand Dermatosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bautista, FJ; Cisneros, JM; Muñoz, RM; Prado, E1
McCabe, D; Storch, G; Weston, B1
Hivnor, C; Shapiro, MS; Shepard, JW; Vittorio, CC1
De Clercq, E; De Vos, R; Degreef, H; Geerinck, K; Lukito, G; Maes, B; Snoeck, R; Vanrenterghem, Y1

Other Studies

4 other study(ies) available for organophosphonates and Hand Dermatosis

ArticleYear
[Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:3

    Topics: Anemia, Hemolytic, Congenital; Antiviral Agents; Cidofovir; Cytosine; Female; Fingers; Gels; Hand Dermatoses; Humans; Organophosphonates; Papillomavirus Infections; Young Adult

2010
Treatment of orf poxvirus lesion with cidofovir cream.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11

    Topics: Administration, Topical; Animals; Antiviral Agents; Child; Cidofovir; Cytosine; Ecthyma, Contagious; Female; Hand Dermatoses; Humans; Orf virus; Organophosphonates; Organophosphorus Compounds; Sheep

2003
Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.
    Archives of dermatology, 2004, Volume: 140, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Hand Dermatoses; Humans; Infusions, Intravenous; Male; Organophosphonates; Organophosphorus Compounds; Warts

2004
A case of human orf in an immunocompromised patient treated successfully with cidofovir cream.
    Journal of medical virology, 2001, Volume: 64, Issue:4

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Ecthyma, Contagious; Female; Hand Dermatoses; Humans; Immunocompromised Host; Orf virus; Organophosphonates; Organophosphorus Compounds; Treatment Outcome

2001